CompanyOverview|NASDAQ:VKTX] Viking Therapeutics Inc. (NASDAQ: VKTX) reported earnings after the market closed on Apr. 23.

The Minnesota Vikings watched Kirk Cousins walk out the door a year ago. Coming off a torn Achilles tendon, the head of the ...

As previously reported, Northcoast analyst Drew May initiated coverage of Viking Holdings (VIK) with a Buy rating and $51 price target The ...

Historian William R. Short rates Viking battle scenes in "The Northman," "Thor," and "How to Train Your Dragon." ...

Oppenheimer lowered the firm’s price target on Viking Therapeutics (VKTX) to $100 from $164 and keeps an Outperform rating on the shares. Despite impressive clinical progress for VK2735 subQ and ...

Barclays analyst Brandt Montour lowered the firm’s price target on Viking Holdings (VIK) to $45 from $46 and keeps an Equal Weight rating on the shares as part of a Q1 earnings preview for the ...

Viking Ocean Cruises and Seabourn Cruise Line are very different cruise providers, even though both fall into the luxury cruise category. Seabourn is considered an ultra-luxury brand with smaller ...

Chelsea have set their asking price at just £35m for Christopher Nkunku this summer according to reports in France. Nkunku has struggled this season, but is still Chelsea’s joint top scorer ...

Pre-earnings options volume in Viking Therapeutics (VKTX) is 1.8x normal with calls leading puts 19:4. Implied volatility suggests the market is anticipating a move near 8.5%, or $2.24 ...

Viking Therapeutics VKTX reported a first-quarter 2025 loss of 41 cents per share, wider than the Zacks Consensus Estimate of a loss of 34 cents. The company had incurred a loss of 26 cents in the ...